Variant report

Variant	nsv1019956
Chromosome Location	chr8:1423117-1462444
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr8:1427569-1428300	GM12878	blood:	n/a	n/a
2	ATF2	chr8:1424365-1424910	GM12878	blood:	n/a	n/a
3	ATF2	chr8:1427575-1428287	GM12878	blood:	n/a	n/a
4	ATF2	chr8:1425049-1425459	GM12878	blood:	n/a	n/a
5	ATF2	chr8:1425073-1425473	GM12878	blood:	n/a	n/a
6	ATF2	chr8:1424498-1424875	GM12878	blood:	n/a	n/a
7	BACH1	chr8:1456764-1456944	H1-hESC	embryonic stem cell:	n/a	n/a
8	BATF	chr8:1425149-1425468	GM12878	blood:	n/a	n/a
9	BATF	chr8:1424524-1424802	GM12878	blood:	n/a	chr8:1424650-1424661 chr8:1424651-1424661
10	BATF	chr8:1427634-1428254	GM12878	blood:	n/a	n/a
11	BATF	chr8:1425979-1426184	GM12878	blood:	n/a	chr8:1426058-1426069
12	BATF	chr8:1424471-1424846	GM12878	blood:	n/a	chr8:1424650-1424661 chr8:1424651-1424661
13	BATF	chr8:1449883-1450156	GM12878	blood:	n/a	n/a
14	BATF	chr8:1426943-1427188	GM12878	blood:	n/a	chr8:1427045-1427056 chr8:1427046-1427056
15	BATF	chr8:1427570-1428283	GM12878	blood:	n/a	n/a
16	BCL11A	chr8:1424440-1424825	GM12878	blood:	n/a	n/a
17	BCL11A	chr8:1427863-1428343	GM12878	blood:	n/a	n/a
18	BCL3	chr8:1428000-1428338	GM12878	blood:	n/a	n/a
19	BCL3	chr8:1425118-1425433	GM12878	blood:	n/a	n/a
20	BCL3	chr8:1424573-1424841	GM12878	blood:	n/a	n/a
21	BCL3	chr8:1424453-1424868	GM12878	blood:	n/a	n/a
22	BHLHE40	chr8:1451931-1451947	GM12878	blood:	n/a	n/a
23	BHLHE40	chr8:1427554-1428286	GM12878	blood:	n/a	n/a
24	BHLHE40	chr8:1434576-1434712	K562	blood:	n/a	chr8:1434605-1434614 chr8:1434605-1434614
25	BHLHE40	chr8:1425211-1425411	GM12878	blood:	n/a	n/a
26	BHLHE40	chr8:1450121-1450295	GM12878	blood:	n/a	n/a
27	CHD2	chr8:1456740-1456982	H1-hESC	embryonic stem cell:	n/a	n/a
28	CTCF	chr8:1439960-1440110	WERI-Rb-1	eye:	n/a	n/a
29	CTCF	chr8:1459314-1459379	GM13976	blood:	n/a	n/a
30	CTCF	chr8:1442460-1442610	GM12864	blood:	n/a	n/a
31	CTCF	chr8:1443219-1443277	H1-hESC	embryonic stem cell:	n/a	chr8:1443235-1443256 chr8:1443238-1443248 chr8:1443233-1443251 chr8:1443255-1443264 chr8:1443236-1443249 chr8:1443231-1443249
32	CTCF	chr8:1443208-1443244	LNCaP	prostate:	n/a	n/a
33	CTCF	chr8:1423842-1423911	K562	blood:	n/a	chr8:1423880-1423893
34	CTCF	chr8:1423802-1423900	MCF-7	breast:	n/a	chr8:1423880-1423893
35	CTCF	chr8:1425500-1425650	GM12867	blood:	n/a	n/a
36	CTCF	chr8:1443218-1443257	MCF-7	breast:	n/a	chr8:1443235-1443256 chr8:1443238-1443248 chr8:1443233-1443251 chr8:1443236-1443249 chr8:1443231-1443249
37	CTCF	chr8:1432800-1432950	GM12864	blood:	n/a	n/a
38	CTCF	chr8:1454917-1454965	LNCaP	prostate:	n/a	n/a
39	CTCF	chr8:1443210-1443278	MCF-7	breast:	n/a	chr8:1443235-1443256 chr8:1443238-1443248 chr8:1443233-1443251 chr8:1443255-1443264 chr8:1443236-1443249 chr8:1443231-1443249
40	CTCF	chr8:1459529-1459564	GM13976	blood:	n/a	n/a
41	CTCF	chr8:1423701-1424016	K562	blood:	n/a	chr8:1423880-1423893
42	CTCF	chr8:1456825-1456985	K562	blood:	n/a	chr8:1456903-1456916
43	CTCF	chr8:1459772-1459828	Medullo	brain:	n/a	n/a
44	CTCF	chr8:1443160-1443310	Hela-S3	cervix:	n/a	chr8:1443235-1443256 chr8:1443238-1443248 chr8:1443233-1443251 chr8:1443255-1443264 chr8:1443236-1443249 chr8:1443231-1443249
45	CTCF	chr8:1456784-1456997	H1-hESC	embryonic stem cell:	n/a	chr8:1456903-1456916
46	CTCF	chr8:1431140-1431290	GM12874	blood:	n/a	n/a
47	CTCF	chr8:1431180-1431330	GM12871	blood:	n/a	n/a
48	CTCF	chr8:1423699-1423975	K562	blood:	n/a	chr8:1423880-1423893
49	CTCF	chr8:1423681-1424069	K562	blood:	n/a	chr8:1423880-1423893
50	CTCF	chr8:1423582-1424010	K562	blood:	n/a	chr8:1423880-1423893

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr8:1444085-1444135	HMEC	breast:	n/a
2	chr8:1462183-1462233	GM12878	blood:	n/a
3	chr8:1423656-1423706	ProgFib	skin:	n/a
4	chr8:1449634-1449684	HEEpiC	esophagus:	n/a
5	chr8:1460633-1460683	HRPEpiC	eye:	n/a
6	chr8:1442292-1442342	CMK	blood:	n/a
7	chr8:1428412-1428462	AG04449	skin:	fetal
8	chr8:1444085-1444135	HMEC	breast:	n/a
9	chr8:1462183-1462233	GM12878	blood:	n/a
10	chr8:1423656-1423706	ProgFib	skin:	n/a
11	chr8:1449634-1449684	HEEpiC	esophagus:	n/a
12	chr8:1460633-1460683	HRPEpiC	eye:	n/a
13	chr8:1442292-1442342	CMK	blood:	n/a
14	chr8:1428412-1428462	AG04449	skin:	fetal
15	chr8:1441985-1442035	RPTEC	kidney:	n/a
16	chr8:1462183-1462233	AG09319	gingival:	n/a
17	chr8:1460718-1460768	SAEC	small airway:	n/a
18	chr8:1446276-1446326	GM12878	blood:	n/a
19	chr8:1439789-1439839	SKMC	muscle:	n/a
20	chr8:1430303-1430353	GM12878	blood:	n/a
21	chr8:1458119-1458169	HCM	heart:	n/a
22	chr8:1423775-1423825	RPTEC	kidney:	n/a
23	chr8:1462183-1462233	GM12891	blood:	n/a
24	chr8:1441386-1441436	HepG2	liver:	n/a
25	chr8:1450031-1450081	GM06990	blood:	n/a
26	chr8:1460633-1460683	HEEpiC	esophagus:	n/a
27	chr8:1431308-1431358	BJ	skin:	n/a
28	chr8:1460718-1460768	HCT-116	colon:	n/a
29	chr8:1458508-1458558	AG10803	skin:	n/a
30	chr8:1423366-1423416	NT2-D1	testis:	n/a
31	chr8:1460569-1460619	HepG2	liver:	n/a
32	chr8:1462183-1462233	Jurkat	blood:	n/a
33	chr8:1423656-1423706	ECC-1	luminal epithelium:	n/a
34	chr8:1458554-1458604	HEEpiC	esophagus:	n/a
35	chr8:1440117-1440167	HCT-116	colon:	n/a
36	chr8:1423775-1423825	SAEC	small airway:	n/a
37	chr8:1439789-1439839	HMEC	breast:	n/a
38	chr8:1455354-1455404	PFSK-1	brain:	n/a
39	chr8:1441539-1441589	GM12892	blood:	n/a
40	chr8:1462183-1462233	SAEC	small airway:	n/a
41	chr8:1448750-1448800	HEEpiC	esophagus:	n/a
42	chr8:1449108-1449158	PANC-1	pancreas:	n/a
43	chr8:1423823-1423873	CMK	blood:	n/a
44	chr8:1449108-1449158	Hela-S3	cervix:	n/a
45	chr8:1460268-1460318	K562	blood:	n/a
46	chr8:1443468-1443518	MCF-7	breast:	n/a
47	chr8:1430303-1430353	BE2_C	brain:	n/a
48	chr8:1428412-1428462	NB4	blood:	n/a
49	chr8:1423656-1423706	HCPEpiC	choroid plexus:	n/a
50	chr8:1455764-1455814	HRCEpiC	kidney:	n/a

No.	Distal block	Cell Line	Cell type
1	chr8:1417041..1419127-chr8:1432833..1434502,2	K562	blood:
2	chr8:1408127..1410812-chr8:1426769..1429337,2	K562	blood:
3	chr8:1386309..1387811-chr8:1433835..1436467,2	K562	blood:

Variant related genes	Relation type
DLGAP2	TF binding region
DLGAP2	CpG island

Extended variants
information (count: 2728 )
Associated
traits (count: 119 )

Variant overlapped rSNPs/rCNVs (count:2728 , 50 per page) page: 1 2 3 4 5 6 7 ... 55

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs565594066	chr8:1423120-1423121	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs527257460	chr8:1423162-1423163	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs369938895	chr8:1423163-1423164	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs566888826	chr8:1423164-1423165	Enhancers Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs181792777	chr8:1423209-1423210	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs186816793	chr8:1423211-1423212	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs549554705	chr8:1423215-1423216	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs569469182	chr8:1423218-1423219	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs538832893	chr8:1423231-1423232	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs148407119	chr8:1423241-1423242	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs112329714	chr8:1423242-1423243	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs144007208	chr8:1423252-1423253	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs113107270	chr8:1423259-1423260	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs190620509	chr8:1423285-1423286	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs566148722	chr8:1423310-1423311	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs562981758	chr8:1423334-1423335	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs146511475	chr8:1423351-1423352	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs141161462	chr8:1423352-1423353	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs183536021	chr8:1423358-1423359	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs76207579	chr8:1423382-1423383	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs540664857	chr8:1423387-1423388	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs560587409	chr8:1423403-1423404	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs187831926	chr8:1423404-1423405	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs151198046	chr8:1423407-1423408	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs569436398	chr8:1423462-1423463	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs111811490	chr8:1423482-1423483	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs569938432	chr8:1423495-1423496	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs567933300	chr8:1423503-1423504	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs189956930	chr8:1423506-1423507	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs182154413	chr8:1423511-1423512	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs116513832	chr8:1423546-1423547	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs113792543	chr8:1423556-1423557	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs557939884	chr8:1423560-1423561	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs567624960	chr8:1423574-1423575	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs140965049	chr8:1423625-1423626	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs556658927	chr8:1423631-1423632	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs536811799	chr8:1423643-1423644	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs545249705	chr8:1423676-1423677	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs559150758	chr8:1423686-1423687	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs188030595	chr8:1423700-1423701	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs541285695	chr8:1423743-1423744	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs2404301	chr8:1423744-1423745	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs150224284	chr8:1423753-1423754	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs113885467	chr8:1423764-1423765	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs563224209	chr8:1423776-1423777	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs138685307	chr8:1423794-1423795	Weak transcription Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs552083531	chr8:1423802-1423803	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs565907803	chr8:1423810-1423811	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs528285036	chr8:1423846-1423847	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs58087050	chr8:1423854-1423855	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:119)

Disease	PMID	Source
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Congenital diaphragmatic hernia	21341218	CNVD
Cancer	18840272	CNVD
Pilocytic astrocytoma	18622384	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Prostate cancer	16573809	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
abnormal development	18461090	CNVD
Crohn''s disease	19220326	CNVD
Psoriasis	19220326	CNVD
Prostate cancer	21965145	CNVD
Prostate cancer	18515986	CNVD
Chronic obstructive pulmonary disease	20378733	CNVD
Autism	18414403	CNVD
Cancer	21183584	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Breast cancer	17603634	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Ovarian cancer	20844748	CNVD
Cervical cancer	17311676	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Schizophrenia	20877625	CNVD
Disorders of sex development	21048976	CNVD
Colorectal cancer	16272173	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Breast cancer	17001317	CNVD
Thyroid cancer	19087340	CNVD
Multiple myeloma	16616336	CNVD
Hepatocellular carcinoma	22174799	CNVD
Heart disease	21282601	CNVD
T-cell lymphomas	19863542	CNVD
Ovarian cancer	22174824	CNVD
Colorectal cancer	21297112	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Salivary gland tumor	18059337	CNVD
Breast cancer	17133270	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Breast cancer	17393978	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Breast cancer	20837533	CNVD
Squamous cell cancer	21044232	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	22429812	CNVD
Non-small cell lung cancer	21044232	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Colorectal cancer	20709793	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Basal cell lymphoma	21115979	CNVD
Breast cancer	21264507	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Prostate cancer	21088497	CNVD
Breast cancer	20940404	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Gastric cancer	17167181	CNVD
Prostate cancer	16705090	CNVD
8p-syndrome	17576883	CNVD
Human rectal carcinomas	16397240	CNVD
Medulloblastoma	16968546	CNVD
Lung adenocarcinoma	19525976	CNVD
Lung cancer	19525976	CNVD
Prostate cancer	17245344	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Cancer	16751803	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Autism	19415332	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Esophageal cancer	21851588	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Breast cancer	21245420	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
Cancer	20164919	CNVD
Breast cancer	21785460	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	20729466	CNVD
Ductal carcinoma	22052326	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21509527	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Epilepsy	22083797	CNVD
Acute myeloid leukemia	21251322	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Breast cancer	21364760	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Liver carcinoma	19366792	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Autism	20531469	CNVD
Breast cancer	20932292	CNVD
Congenital diaphragmatic hernia	21064195	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Ependymoma	20639864	CNVD
Ovarian cancer	22355333	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:442 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr8:1420600-1425200	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
2	chr8:1422600-1423600	Enhancers	Primary T helper cells fromperipheralblood	blood
3	chr8:1422600-1424200	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
4	chr8:1422600-1424400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
5	chr8:1422800-1423200	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
6	chr8:1422800-1424000	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
7	chr8:1423000-1423200	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
8	chr8:1423200-1423800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
9	chr8:1423200-1424200	Enhancers	Primary T regulatory cells fromperipheralblood	blood
10	chr8:1423200-1425200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
11	chr8:1423400-1425400	Enhancers	Primary T helper cells PMA-I stimulated	--
12	chr8:1423600-1424000	Weak transcription	Primary T helper cells fromperipheralblood	blood
13	chr8:1423600-1424200	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
14	chr8:1423800-1424400	Enhancers	Primary T cells fromperipheralblood	blood
15	chr8:1424000-1424200	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
16	chr8:1424000-1424600	ZNF genes & repeats	GM12878-XiMat	blood
17	chr8:1424000-1426000	Enhancers	Primary T helper cells fromperipheralblood	blood
18	chr8:1424200-1424400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr8:1424200-1424400	Bivalent Enhancer	Fetal Kidney	kidney
20	chr8:1424200-1424600	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
21	chr8:1424200-1424800	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
22	chr8:1424200-1425000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
23	chr8:1424200-1425200	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
24	chr8:1424200-1425200	Enhancers	Adipose Nuclei	Adipose
25	chr8:1424200-1425400	Enhancers	Primary hematopoietic stem cells	blood
26	chr8:1424200-1425400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
27	chr8:1424200-1425400	Enhancers	Spleen	Spleen
28	chr8:1424200-1425800	Enhancers	Pancreas	Pancrea
29	chr8:1424400-1424800	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
30	chr8:1424400-1425000	Enhancers	Primary monocytes fromperipheralblood	blood
31	chr8:1424400-1425000	Flanking Active TSS	Primary T cells fromperipheralblood	blood
32	chr8:1424400-1425200	Flanking Active TSS	Primary T helper 17 cells PMA-I stimulated	--
33	chr8:1424600-1425400	Enhancers	Primary hematopoietic stem cells short term culture	blood
34	chr8:1424600-1425600	Enhancers	Primary B cells from peripheral blood	blood
35	chr8:1424600-1427200	Enhancers	GM12878-XiMat	blood
36	chr8:1424600-1427400	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
37	chr8:1424800-1425000	Enhancers	Brain Anterior Caudate	brain
38	chr8:1424800-1425400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
39	chr8:1424800-1425400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
40	chr8:1424800-1425600	Bivalent Enhancer	Fetal Muscle Trunk	muscle
41	chr8:1425000-1425400	Bivalent Enhancer	Fetal Muscle Leg	muscle
42	chr8:1425000-1427400	Weak transcription	Brain Anterior Caudate	brain
43	chr8:1425000-1427600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
44	chr8:1425000-1427800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
45	chr8:1425000-1428200	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
46	chr8:1425200-1425400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
47	chr8:1425200-1425400	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
48	chr8:1425200-1425400	Bivalent Enhancer	Adipose Nuclei	Adipose
49	chr8:1425200-1425400	Enhancers	Brain Germinal Matrix	brain
50	chr8:1425200-1425600	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links